Medicine Overview of Glimipack MP 2mg/500mg/15mg Tablet
Glimipack MP 2mg/500mg/15mg Tablet is used in the treatment of type 2 diabetes
Hypoglycemia (low blood sugar level), Nausea, Altered taste, Diarrhoea, Stomach pain, Headache, Edema, Weight gain, Anemia, Blurred vision, Bone fracture, Upper respiratory tract infection.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimipack MP 2mg/500mg/15mg Tablet is to be taken with food.
Glimipack MP 2mg/500mg/15mg Tablet may cause stomach upset if taken empty stomach.
Glimipack MP 2mg/500mg/15mg Tablet is a combination of three antidiabetic medicines: Glimepiride, metformin, pioglitazone. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas to lower the blood glucose. Metformin is a biguanide which lowers glucose production in the liver, delays glucose absorption from intestines and increases the body's sensitivity to insulin. Pioglitazone is a thiazolidinedione which also increases the body's sensitivity to insulin.
In Depth Information on Glimipack MP 2mg/500mg/15mg Tablet
Glimipack MP Tablet related warnings
Taking pioglitazone with alcohol may affect blood glucose levels in patients with diabetes.
WEIGH RISKS VS BENEFITS
Glimipack MP 2mg/500mg/15mg Tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Glimipack MP 2mg/500mg/15mg Tablet is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Monitor the breastfed baby’s blood sugar during treatment with Glimipack MP 2mg/500mg/15mg Tablet
Your ability to drive may be affected if your blood sugar is
low or high. If this happens, do not drive.
Glimipack MP 2mg/500mg/15mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Glimipack MP 2mg/500mg/15mg Tablet may be needed. Please consult your doctor.
Use of Glimipack MP 2mg/500mg/15mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Glimipack MP 2mg/500mg/15mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Glimipack MP 2mg/500mg/15mg Tablet may be needed. Please consult your doctor.
Use of Glimipack MP 2mg/500mg/15mg Tablet is not recommended in patients with severe liver disease.
One of the following vendor pharmacies will deliver Glimipack MP 2mg/500mg/15mg Tablet: MAX, PPR, GBL, SBA, OLT, DHR, PTI, EMB, NTB, GTC, DFP, SWA, SHD, PRN, VRS, HEX, ZVP, STA, SDM, BHP, ATP, DGN, OIP, AAR, IPL, WSI, PNT, JVO, ENP, AGT, DPL, LHA, MAK, PLT, FGH, RSS, MMS, NDP, OWP, GTK, DPP, NWP, BTM, USF, AAY, OHM, ADT, RKS, ABP, PVP, ARD, NSL, SWP, SCH, BMJ, MDO, SYN, WHL, RUS, BIO, 9T9, RPP, RJH, SAF, NNH, JIV, DLP, SSA, HMP, GPP, MSD, BAL, IAD, SVH, RHW, ANT, MPC, NVY, MOM, PEN, BSN, AMR, HBV, PWN, NXG, MLC, AVN, TRP, AYU, HAT, RSA, GNC, CLT, JMJ, BBS, KHH, TNH, EQN, HIP, UMP, HPC, NVL, SBL, DDR, DYG, GPT, MAM, RHL, BDN, RWP, THP, LCC, JVN, ATL, ZEL, SGC, SHP, INC, SJP, HGI, SAT